Drug intelligence / Profile preview

acetylsalicylic acid + pantoprazole

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

**Acetylsalicylic acid + pantoprazole** is an oral fixed-dose combination of the antiplatelet small molecule acetylsalicylic acid and the proton-pump inhibitor pantoprazole. Acetylsalicylic acid irreversibly inhibits platelet cyclooxygenase-1, suppressing thromboxane A2 production and platelet aggregation to support secondary prevention of cardiovascular and cerebrovascular events. Pantoprazole irreversibly inhibits the gastric hydrogen-potassium ATPase, lowering gastric acid secretion and reducing the risk of aspirin-associated gastroduodenal injury, ulceration, and bleeding. Fixed-dose capsule products have been studied at acetylsalicylic acid 100 mg or 150 mg plus pantoprazole 20 mg, and marketed products also include an 81 mg acetylsalicylic acid plus 20 mg pantoprazole capsule.

Brand names
Pan ASP
Other names
ASA + pantoprazoleacetylsalicylic acid/pantoprazoleaspirin + pantoprazoleaspirin/pantoprazole
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)ATP4A (Potassium–transporting ATPase alpha chain 1)

Beyond the preview

Go deeper on acetylsalicylic acid + pantoprazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetylsalicylic acid + pantoprazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call